Jürgen Reefschläger

Title: The Innovative Journey of Jürgen Reefschläger

Introduction

Jürgen Reefschläger, an accomplished inventor based in Oldenburg, Germany, has made significant contributions to the field of medicinal chemistry. With a portfolio of four patents, his work primarily focuses on antiviral agents, offering promising advancements in the treatment of diseases, especially those caused by cytomegaloviruses.

Latest Patents

Among his notable patents, Reefschläger has developed dihydroquinazolines with antiviral properties. His latest inventions include:

1. **2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents** - This invention relates to dihydroquinazolines, along with methods for their production, and their application in creating medicaments for the treatment and prevention of diseases, particularly as antiviral agents against cytomegaloviruses.

2. **Substituted dihydroquinazolines** - This patent involves substituted dihydroquinazolines, detailing preparation processes and their use in developing medicines aimed at treating and preventing diseases, specifically as antiviral agents against cytomegaloviruses.

Career Highlights

Throughout his career, Jürgen Reefschläger has been associated with reputable companies in the pharmaceutical sector, including Bayer Healthcare and Bayer Schering Pharma. His expertise and innovative spirit have led to breakthroughs that continue to impact the industry positively.

Collaborations

Reefschläger has collaborated with talented coworkers such as Tobias Wunberg and Holger Zimmermann. Their collective efforts have facilitated progress in pharmaceutical innovation, enhancing the scope of antiviral treatments.

Conclusion

Jürgen Reefschläger stands out in the realm of inventions, particularly in developing antiviral agents to combat cytomegaloviruses. His extensive patent portfolio reflects his dedication to improving health outcomes and showcases the importance of innovation in pharmaceutical research.